{
    "Trade/Device Name(s)": [
        "ADVIA Centaur Active-B12 (Holotranscobalamin) (AB12) assay",
        "ADVIA Centaur AB12 assay"
    ],
    "Submitter Information": "Axis-Shield Diagnostics Ltd.",
    "510(k) Number": "K172133",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160757"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CDD"
    ],
    "Summary Letter Date": "September 26, 2017",
    "Summary Letter Received Date": "September 28, 2017",
    "Submission Date": "October 25, 2017",
    "Regulation Number(s)": [
        "21CFR862.1810"
    ],
    "Regulation Name(s)": [
        "Vitamin B12 test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Holotranscobalamin (holoTC)",
        "Vitamin B12 (Active-B12)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur XP system"
    ],
    "Method(s)/Technology(ies)": [
        "Two-step direct immunoassay",
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Active-B12 (Holotranscobalamin) assay for quantitative measurement of holotranscobalamin in human serum using chemiluminescent immunoassay technology",
    "Indications for Use Summary": "In vitro diagnostic use in the quantitative measurement of holotranscobalamin in human serum as an aid in the diagnosis and treatment of vitamin B12 deficiency",
    "fda_folder": "Clinical Chemistry"
}